| 000 | 01002 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513051504.0 | ||
| 264 | 0 | _c19940908 | |
| 008 | 199409s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(94)91371-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDurand, J M | |
| 245 | 0 | 0 |
_aInterferon-alpha 2b for refractory ocular Behçet's disease. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJul 1994 |
||
| 300 |
_a333 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter; Comment | ||
| 650 | 0 | 4 |
_aBehcet Syndrome _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRetinitis _xetiology |
| 700 | 1 | _aSoubeyrand, J | |
| 773 | 0 |
_tLancet (London, England) _gvol. 344 _gno. 8918 _gp. 333 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(94)91371-4 _zAvailable from publisher's website |
| 999 |
_c7913607 _d7913607 |
||